Emmaus Life Sciences, Inc. – OTC:EMMAW
Emmaus Life Sciences stock price today
Emmaus Life Sciences stock price monthly change
Emmaus Life Sciences stock price quarterly change
Emmaus Life Sciences stock price yearly change
Emmaus Life Sciences key metrics
Market Cap | N/A |
Enterprise value | 3.21B |
P/E | -0.06 |
EV/Sales | 156.04 |
EV/EBITDA | -252.01 |
Price/Sales | 155.57 |
Price/Book | -149.48 |
PEG ratio | N/A |
EPS | -0.32 |
Revenue | 20.61M |
EBITDA | -12.76M |
Income | -15.94M |
Revenue Q/Q | -51.69% |
Revenue Y/Y | -11.03% |
Profit margin | -77.37% |
Oper. margin | -29.73% |
Gross margin | 83.93% |
EBIT margin | -29.73% |
EBITDA margin | -61.92% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEmmaus Life Sciences stock price history
Emmaus Life Sciences stock forecast
Emmaus Life Sciences financial statements
| Mar 2021 | 5.33M | -8.42M | -157.86% |
|---|---|---|---|
| Jun 2021 | 6.48M | 2.48M | 38.36% |
| Sep 2021 | 5.76M | -3.15M | -54.65% |
| Dec 2021 | 3.02M | -6.86M | -227.22% |
| Mar 2021 | 62223000 | 74.89M | 120.37% |
|---|---|---|---|
| Jun 2021 | 63279000 | 72.65M | 114.82% |
| Sep 2021 | 60057000 | 75.15M | 125.14% |
| Dec 2021 | 56734000 | 78.18M | 137.81% |
| Mar 2021 | -4.00M | -1.76M | 7.04M |
|---|---|---|---|
| Jun 2021 | 242K | -2.19M | -135K |
| Sep 2021 | 1.64M | -1.28M | 300K |
| Dec 2021 | 865K | -1.12M | 200K |
Emmaus Life Sciences other data
| Period | Buy | Sel |
|---|---|---|
| May 2021 | 73054 | 0 |
| Jun 2021 | 24821 | 0 |
| Jul 2021 | 28700 | 0 |
| Aug 2021 | 62094 | 0 |
| Sep 2021 | 24582 | 0 |
| Oct 2021 | 4000 | 0 |
| Nov 2021 | 306042 | 0 |
| Dec 2021 | 63300 | 0 |
| Jan 2022 | 10000 | 0 |
| Feb 2022 | 21750 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 3,250 | $1.49 | $4,843 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 5,250 | $1.47 | $7,718 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 7,000 | $1.43 | $10,010 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 6,250 | $1.4 | $8,750 | ||
Purchase | LUI ALFRED FU KONG director | Common stock, $0.001 par value | 10,000 | $1.58 | $15,800 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 7,000 | $1.58 | $11,060 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 6,800 | $1.56 | $10,608 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 2,700 | $1.57 | $4,239 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 1,000 | $1.6 | $1,600 | ||
Purchase | NIIHARA YUTAKA director, 10 perc.. | Common stock, $0.001 par value | 1,200 | $1.48 | $1,776 |
-
What's the price of Emmaus Life Sciences stock today?
One share of Emmaus Life Sciences stock can currently be purchased for approximately $0.03.
-
When is Emmaus Life Sciences's next earnings date?
Unfortunately, Emmaus Life Sciences's (EMMAW) next earnings date is currently unknown.
-
Does Emmaus Life Sciences pay dividends?
No, Emmaus Life Sciences does not pay dividends.
-
What is Emmaus Life Sciences's stock symbol?
Emmaus Life Sciences, Inc. is traded on the OTC under the ticker symbol "EMMAW".
-
How do i buy shares of Emmaus Life Sciences?
Shares of Emmaus Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Emmaus Life Sciences went public?
Emmaus Life Sciences, Inc. is publicly traded company for more then 4 years since IPO on 16 Sep 2021.